Cory Renauer
Cory Renauer is a contributing Motley Fool healthcare analyst covering pharmaceuticals, biotechnology, and medical devices. Previously, Cory was a laboratory technician for the American Red Cross. He holds a bachelor’s degree in biology from Oakland University.
Recent Articles by Cory Renauer

Jan 16, 2025
by Cory Renauer
Down 79%, Is Moderna Stock a Bad-News Buy on the Dip?

Jan 12, 2025
by Cory Renauer
Can Walgreens Boots Alliance Stock Keep Soaring?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.